EMA — authorised 15 November 2023
- Application: EMEA/H/C/005731
- Marketing authorisation holder: Proveca Pharma Limited
- Local brand name: Aqumeldi
- Indication: Treatment of heart failure.
- Status: approved
🇪🇺 Vasotec in European Union
EMA authorised Vasotec on 15 November 2023
Marketing authorisation
Vasotec in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in European Union
Frequently asked questions
Is Vasotec approved in European Union?
Yes. EMA authorised it on 15 November 2023.
Who is the marketing authorisation holder for Vasotec in European Union?
Proveca Pharma Limited holds the EU marketing authorisation.